PARP inhibitors are a type of cancer drug. PARP stands for poly adenosine diphosphate-ribose polymerase, a type of enzyme that helps repair DNA damage in cells. PARP inhibitors work by preventing ...

Poly adenosine diphosphate-ribose polymerase inhibitors, an important class of anticancer drugs, employ synthetic lethality strategy and are particularly effective against cancers with genetic ...

Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel.

Use of palliative care among patients with metastatic breast cancer at a safety net hospital. This is an ASCO Meeting Abstract from the 2018 Palliative and Supportive Care in Oncology Symposium. This ...

In the body, adenosine helps in cellular energy transfer by forming molecules like adenosine triphosphate (ATP) and adenosine diphosphate ... drug Dipyridamole is an inhibitor of the enzyme ...

Via this mechanism, platelet aggregation is inhibited in response to various stimuli such as platelet activating factor (PAF), collagen and adenosine diphosphate (ADP). Aspirin inhibits platelet ...

Parkinson’s disease is a common and debilitating age-related neurodegenerative disease that is increasing rapidly in prevalence and is expected to affect 14 million people worldwide by 2040.

Pre- and post-comprehensive geriatric assessment in older patients with hematological malignancy before allogeneic stem cell transplantation. This is an ASCO Meeting Abstract from the 2018 Palliative ...

Whereas one of the two catalytic sites of ADK is responsible for this reaction, a second site is reserved for ATP and adenosine diphosphate ... agonists and ADK inhibitors. As compared to ...